Gleevec Cost in 2026: Prices & How to Pay Less

If you have been prescribed Gleevec (imatinib mesylate) for chronic myeloid leukemia (CML), a gastrointestinal stromal tumor (GIST), or another condition, one of the first questions you likely have is a simple one: how much is this going to cost? It is a fair question, and the honest answer is that Gleevec cost can be shocking at first glance, often thousands of dollars per month at the pharmacy counter before any assistance is applied.

The good news is that almost no patient needs to pay the full sticker price. Between generic imatinib, manufacturer programs, foundation grants, and copay assistance, the real out-of-pocket cost can drop dramatically, and in many cases to little or nothing. This guide walks through what Gleevec actually costs in 2026, why the generic is not always as cheap as people expect, and the specific ways to bring your price down.

At QuickRx Specialty Pharmacy, our team helps patients navigate every one of these options. To speak with a specialist about lowering your Gleevec cost, call us at (917) 830-2525.

How Much Does Gleevec Cost in 2026?

The list price of brand-name Gleevec is high. Based on Average Wholesale Price (AWP) benchmarks, brand-name Gleevec runs roughly $112 per 100 mg tablet and about $405 per 400 mg tablet. For a common 400 mg once-daily regimen, that places the brand-name list price in the range of $12,000 or more for a 30-day supply.

Generic imatinib mesylate is substantially cheaper at the cash-discount level. Using widely available pharmacy discount programs, a 30-day supply of generic imatinib 400 mg commonly falls in the range of roughly $100 to $130 cash, with prices varying by pharmacy and location. It is worth understanding, though, that AWP benchmarks for generic imatinib span a very wide range depending on the manufacturer, from a few dollars per tablet up to nearly the brand price, which is why two patients can be quoted very different numbers for the “same” generic drug.

The table below compares what the major drug-pricing resources report for imatinib in 2026, for the common 400 mg, 30-day supply. These figures are published by third-party pricing sites and update frequently, so treat them as reference points rather than quotes. Your actual price depends on your pharmacy, dose, manufacturer, and insurance.

Two things stand out. First, the cash-discount price for generic imatinib clusters around $100 to $120 at the most competitive pharmacies, but the same drug can cost several hundred dollars or more at a different pharmacy on the same day, so comparing pharmacies genuinely matters. Second, with manufacturer or foundation assistance, eligible patients may pay as little as $0, far below any of the cash prices above.

The enormous gap between the brand list price and the eventual out-of-pocket cost is exactly why it pays to understand your options before you ever pick up the prescription. If you would like help comparing what you would actually pay, call QuickRx at (917) 830-2525.

Why Is Gleevec So Expensive?

Gleevec was approved by the FDA on May 10, 2001, and it transformed CML from a fatal diagnosis into a manageable chronic condition for most patients. For roughly two decades as a brand-name-only drug, its price climbed steadily, and by the time generic competition arrived its annual cost for a typical patient had reached well into six figures.

Several factors keep imatinib expensive even today. It is a specialty oral oncology medication, which places it on the highest tiers of most insurance formularies. It is taken long-term, often for years or indefinitely in CML, so the monthly cost compounds. And as discussed below, the arrival of the generic did not produce the dramatic price collapse many patients expected.

Does Generic Imatinib Cost Less?

Yes, generic imatinib generally costs far less than brand-name Gleevec, but the story is more complicated than “the generic is cheap.” Generic imatinib became available in the United States in 2016 after Gleevec lost patent protection, and it is the same active ingredient as the brand. In principle, generic competition should drive prices down sharply.

In practice, the early years of generic imatinib were a well-documented disappointment. Research found that the introduction of the generic produced only modest savings at first, with generic imatinib initially priced close to the brand. Analysts and patient advocates had anticipated steep reductions that were slow to materialize, in part because prescribing sometimes stayed with brand-name Gleevec and because the generic launched at a high price point.

Today the picture is better at the cash-discount level, where generic imatinib is widely available in the roughly $100 to $130 range for a 30-day supply of the 400 mg tablet. But the wide AWP range across manufacturers means your insurance-adjudicated price or your pharmacy’s quote can still land much higher than that discount-card figure. This is the single most confusing thing for patients shopping on price, and it is why comparing your specific options matters.

For a deeper look at generic imatinib specifically, including how it compares to brand-name Gleevec and how to access it affordably, see our guide to generic imatinib mesylate.

Get Help Lowering Your Gleevec Cost

917-830-2525

Gleevec Cost Without Insurance

For uninsured patients, the choice between brand and generic makes an enormous difference. Paying full retail for brand-name Gleevec can mean thousands of dollars per month, an amount that is simply out of reach for most people. Generic imatinib at a cash-discount price brings that down to roughly $100 to $130 per month for the common 400 mg dose, though again the exact figure depends on the pharmacy and the manufacturer of the generic.

Uninsured patients also have paths that have nothing to do with discount cards. It is worth knowing that the Novartis Patient Assistance Foundation discontinued coverage of Gleevec as of January 2025, largely because the generic made the medication far more affordable. Today, the most reliable way for an uninsured patient to lower the cost is a combination of generic imatinib and any financial assistance they qualify for. QuickRx handles that legwork for you, reviewing your situation and applying any assistance you are eligible for. See how we help on our Gleevec copay assistance page.

Gleevec Cost With Insurance

Having insurance helps, but it does not always make Gleevec affordable. Because imatinib sits on specialty drug tiers, insured patients often face high copays or coinsurance, sometimes hundreds or even thousands of dollars per month, especially early in the year before a deductible is met or during a Medicare Part D coverage gap.

This is where copay assistance becomes essential. Eligible commercially insured patients may qualify for manufacturer copay support that can reduce a brand-name prescription to a small fixed amount per fill. For patients on Medicare and other government plans, who are typically excluded from manufacturer copay cards, independent foundation grants may be available instead. The right option depends entirely on your insurance type, which is why a personalized review is worthwhile. QuickRx handles that review and the paperwork for you. Visit our Gleevec copay assistance page to get started.

How to Lower Your Gleevec Cost

No single tactic works for everyone, but one of the following almost always helps. Here are the main ways patients reduce what they pay for imatinib:

1. Switch to generic imatinib where appropriate: Generic imatinib mesylate is FDA-approved and held to the same standards of quality and effectiveness as brand-name Gleevec. Talk with your doctor and check your insurance, since plans may prefer one version over the other.
2. Apply for any financial assistance you qualify for: Although the Novartis Patient Assistance Foundation discontinued Gleevec in January 2025, other forms of financial help may still lower your out-of-pocket cost. QuickRx can review your situation and apply any assistance you are eligible for.
3. Use copay assistance: Commercially insured patients may dramatically reduce their copay through manufacturer programs; Medicare and Medicaid patients may qualify for independent foundation grants instead.
4. Compare pharmacies: Cash-discount prices for generic imatinib vary meaningfully between pharmacies. A locally owned specialty pharmacy will often work harder to find you the best price than a large chain.
5. Plan ahead for the Medicare coverage gap: If you are on Medicare Part D, prepare for the coverage gap before it hits so you are not caught off guard by a sudden cost spike.

The key takeaway is that the price on the shelf is rarely the price you have to pay. With the right combination of generic substitution, assistance programs, and copay support, most patients can bring their Gleevec cost down to a manageable amount, and many reach zero.

How QuickRx Helps Lower Your Gleevec Cost

At QuickRx Specialty Pharmacy, helping patients afford their medication is the core of what we do. Our dedicated team handles the entire process for you:

1. Insurance review: We analyze your coverage to understand exactly what you would pay.
2. Program identification: We identify every assistance program, copay card, and foundation grant you may qualify for.
3. Application handling: We complete and submit the paperwork on your behalf.
4. Ongoing monitoring: We track your assistance so coverage does not lapse.
5. Renewal management: We proactively reapply when programs renew so you never lose your savings.

Our copay assistance service is always free to patients. We are compensated as your pharmacy when we fill your prescription, never by charging you for the help.

To start lowering your Gleevec cost today, call (917) 830-2525 or apply through our Gleevec copay assistance page.

Ready to Pay Less for Imatinib?

Start Your Application

Frequently Asked Questions

How much does Gleevec cost per month in 2026?

Brand-name Gleevec has a list price of roughly $12,000 or more for a 30-day supply of the common 400 mg daily dose, based on AWP benchmarks. Generic imatinib at a cash-discount price is far lower, commonly around $100 to $130 per month for the 400 mg tablet, though prices vary by pharmacy and location. With manufacturer or foundation assistance, eligible patients may pay as little as $0. Call QuickRx at (917) 830-2525 to find out what you would actually pay.

Does generic imatinib cost less than brand-name Gleevec?

Yes, generic imatinib generally costs much less than brand-name Gleevec, especially at the cash-discount level. However, when generic imatinib first launched in 2016, the savings were smaller than expected, and generic pricing still varies widely depending on the manufacturer. Your insurance-adjudicated price can differ significantly from a discount-card price. See our generic imatinib guide for details.

How much does imatinib cost without insurance?

Without insurance, brand-name Gleevec can cost several thousand dollars per month at full retail. Generic imatinib at a cash-discount price is typically around $100 to $130 per month for the 400 mg dose. Note that the Novartis Patient Assistance Foundation discontinued Gleevec coverage as of January 2025, so uninsured patients today are usually better served by generic imatinib plus any financial assistance they qualify for. Our team can help you find the lowest cost, start on our Gleevec copay assistance page.

Why is Gleevec so expensive?

Gleevec is a specialty oral oncology medication placed on the highest insurance formulary tiers, and it is taken long-term, so monthly costs add up. Its brand-name price climbed steadily over roughly two decades. Even after generic imatinib arrived in 2016, prices came down more slowly than expected, so the drug remains costly for many patients.

Is generic imatinib as effective as brand-name Gleevec?

Generic imatinib mesylate is FDA-approved and held to the same standards of quality, strength, and effectiveness as brand-name Gleevec. Some patients or prescribers prefer to stay on the brand, and insurance plans may cover one version over the other, so discuss the choice with your doctor.

Can I get help paying for Gleevec if I have Medicare?

Yes. Medicare patients are usually excluded from manufacturer copay cards, but independent foundation grants may be available to help cover out-of-pocket costs, which is especially valuable during the Part D coverage gap. QuickRx helps Medicare patients identify and apply for these options. Call (917) 830-2525 to discuss your situation.

How can I lower my out-of-pocket cost for imatinib?

The main paths are switching to generic imatinib where appropriate, applying for manufacturer patient assistance if you are uninsured, using copay assistance if you are commercially insured, seeking foundation grants if you are on Medicare, and comparing pharmacy cash prices. Combining these often brings the cost down to a manageable amount or to zero.

Does QuickRx charge for help with Gleevec costs?

No. QuickRx never charges patients for copay assistance or cost-reduction help. The service is completely free to you. We are compensated as your pharmacy when we fill your prescription, never by charging you for the help.

Additional Resources & Support

Get Help With Gleevec Costs:

• 📋 Apply for Gleevec Copay Assistance
• 💊 Generic Imatinib Mesylate Guide
• 🤝 Apply for Imatinib Financial Assistance
• 📞 Call: (917) 830-2525
• ✉️ Contact QuickRx Specialty Pharmacy

Authoritative Medical Resources:

For reliable medical information about chronic myeloid leukemia and imatinib treatment, these authoritative resources are a good starting point:

• National Cancer Institute – CML Treatment Information
• MedlinePlus – Imatinib
• American Cancer Society – CML Overview
• U.S. Food and Drug Administration – Drug Information

References

1. Gleevec (imatinib mesylate) Prescribing Information. Novartis Pharmaceuticals Corporation.
2. Imatinib (Lexi-Drugs). UpToDate/Lexicomp. AWP pricing and clinical data accessed 2026.
3. Drugs.com, GoodRx, and SingleCare published price guides for Gleevec and imatinib. Pricing data accessed June 2026; figures update frequently.
4. National Cancer Institute. Chronic Myelogenous Leukemia Treatment (PDQ).
5. MedlinePlus. Imatinib.

Gleevec® is a registered trademark of Novartis AG. QuickRx Specialty Pharmacy is not affiliated with Novartis or any pharmaceutical manufacturer. We are an independent specialty pharmacy dedicated to helping patients afford their medications. Pricing figures are approximate, vary by pharmacy and insurance, and change frequently.